Sign in
ASPE Stock Price, Chart, Stats & News
Aspen Neuroscience Inc.
Save
Aspen Neuroscience Inc. (ASPE) does not currently pay a dividend.
372.50M
Market cap
–
Current P/E
–
Forward P/E
ASPE chart
About
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company was founded by Jeanne F.
Similar securities
Based on sector and market capitalization
Report issue